The Russian market in "a green zone", oil grew by 4,5%

The external background still dictates "omicron". Information that vaccines will cope with a new strain or that "omicron" is less killing the predecessors could facilitate the atmosphere. But while such news are not present, investors discuss the statement of CEO of Moderna, Inc that vaccines will be probably less effective against "omicron", than against "delta". On development a new vaccine some months will leave and as much it is required on its mass production. Therefore now the markets very sensitively react to all news about "omicron" and vaccines against it...